Investment Team

Augustine Lawlor
Christopher K. Mirabelli, Ph.D.
Douglas E. Onsi

Senior Advisors and Fund III-VIII Partners

James H. Cavanaugh, Ph.D.
John W. Littlechild
Harold R. Werner

Augustine Lawlor

Gus Lawlor has been a managing director of HealthCare Ventures since 2000. He was previously chief operating officer of LeukoSite, Inc., a HealthCare Ventures III, IV, and V company. Before joining LeukoSite, he was chief financial officer and vice president of corporate development for Alpha-Beta Technology. He held similar positions at BioSurface Technology and Armstrong Pharmaceuticals. He was previously a management consultant with KPMG Peat Marwick. Mr. Lawlor is a member of the board of directors of the Slater Center in Providence, Rhode Island. He received a Masterís degree in Public and Private Management from Yale University.

Back to top

Christopher K. Mirabelli, Ph.D.

Chris Mirabelli joined HealthCare Ventures as a managing director in 2000. Dr. Mirabelli was chairman of the board and chief executive officer of LeukoSite, Inc. from 1993 through 1999, a company in which HealthCare Ventures was the lead investor. He was a co-founder of Isis Pharmaceuticals. He was previously with SmithKline and French Laboratories R&D Division. He is a member of the board of advisors of the Accelerator Fund at Harvard Medical School. He received his Doctor of Philosophy degree in molecular pharmacology from Baylor College of Medicine in Houston, Texas.

Back to top

Douglas E. Onsi

Doug Onsi joined HealthCare Ventures in 2007. He was previously at Genzyme Corporation, where he served in roles as Vice President, Campath Product Operations and Portfolio Management, Oncology and as Vice President, Business Development. Prior to joining Genzyme, Doug was chief financial officer of Tolerx, Inc., a HealthCare Ventures VI company. Before joining Tolerx, he was in business development at LeukoSite, a HealthCare Ventures III, IV, and V company. He began his career as an attorney at Bingham Dana LLP. Mr. Onsi is a member of the business and scientific advisory board for FastForward, a subsidiary of the National Multiple Sclerosis Society, and on the Cornell University Council. He received a Juris Doctor degree from the University of Michigan Law School and an undergraduate degree in biology from Cornell University.

Back to top

James H. Cavanaugh, Ph.D.

James Cavanaugh has been a managing director of HealthCare Ventures since 1989. He was previously president of SmithKline & French Laboratories-U.S., the domestic pharmaceutical division of SmithKline Beckman Corporation. He had been president of SmithKline Beckman's clinical laboratory business and President of Allergan International. He served as staff assistant to President Nixon for Health Affairs and then deputy director of the presidentís Domestic Council. Under President Ford, he was a deputy assistant to the President for domestic affairs and deputy chief of the White House. He has served as deputy assistant secretary for health and scientific affairs in the United States Department of Health, Education and Welfare, special assistant to the Surgeon General, United States Public Health Services, and director, Office of Comprehensive Health Planning. He began his career as a member of the faculty of the Graduate College and the College of Medicine at the University of Iowa where he received his Masterís and Doctorate degrees.

Back to top

John W. Littlechild

John Littlechild has been a managing director of HealthCare Ventures since 1992. He has been in the venture capital industry since 1980 when he joined Citicorp Venture Capital in London. He subsequently joined the Advent Group, opening the London office of Advent U.K. and becoming an early general partner of Advent International in Boston. Prior to his career in venture capital, he held marketing and financial management positions with Rand, Xerox and ICI. Mr. Littlechild is a member of the board of fellows of the Council for Harvard Medicine. He received his Master in Business Administration degree from Manchester Business School.

Back to top

Harold R. Werner

Hal Werner was a co-founder of HealthCare Ventures in 1985. Prior to the formation of HealthCare Ventures, Mr. Werner was director of new ventures for Johnson & Johnson Development Corporation. Before joining Johnson & Johnson, he was senior vice president of Robert S. First, Inc., an international healthcare consulting firm. He received his Master in Business Administration degree from the Harvard Graduate School of Business Administration.

Back to top

Nothing in this website constitutes an offer to sell, or a solicitation of an offer to buy, any securities.
Rev 10/2008 ©1990-2009 HealthCare Ventures LLC